[Ocular disorders in SMON (subacute myelo-optico neuropathy), especially neuro-retinal lesions].
D000005:Abdomen; D000284:Administration, Oral; D000293:Adolescent; D000818:Animals; D001344:Autopsy; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007455:Iodine / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009187:Myelitis / Q000139:chemically induced / Q000473:pathology*; D009902:Optic Neuritis / Q000139:chemically induced / Q000473:pathology*; D010146:Pain; D011804:Quinolines / Q000009:adverse effects; D011817:Rabbits; D014795:Visual Pathways / Q000473:pathology
D011804:Quinolines; D007455:Iodine